Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

SURMODICS INC Director's Dealing 2016

May 31, 2016

32845_dirs_2016-05-31_9c75ce2f-64e3-4987-aabf-66cc98222ed9.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: SURMODICS INC (SRDX)
CIK: 0000924717
Period of Report: 2016-05-27

Reporting Person: KNIGHT SUSAN E (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2016-05-27 Common Stock S 1001 $22.711 Disposed 16470 Direct

Footnotes

F1: Reflects the weighted average price of 1,001 shares of common stock of Surmodics,Inc. sold by the reporting person in multiple transactions on May 27, 2016 with sale prices ranging from $22.70 to $22.73 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

F2: The amount beneficially owned includes 5,693 restricted stock units (RSUs) that vest on service-based vesting dates that will be settled in shares of the issuer's common stock on a 1 for 1 basis when the reporting persons' service as a director ends.